Imidazolone as an Amide Bioisostere in the Development of β-1,3-N-Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors.

Jeffrey J Jackson, Aaron C Siegmund,Wen-Ju Bai,Anthony B Reed,Adam B Birkholz,Iain D G Campuzano, Amandine Créquer-Grandhomme, Ruozhen Hu, Rucha V Modak,Athena Sudom, Noelle Javier, Christiana Sanders,Mei-Chu Lo, Fang Xie,Victor J Cee,Paolo Manzanillo,John G Allen

Journal of medicinal chemistry(2023)

引用 0|浏览2
暂无评分
摘要
B3GNT2 is responsible for elongation of cell surface long-chain polylactosamine, which influences the regulation of the immune response, making it an attractive target for immunomodulation. In the development of amide containing B3GNT2 inhibitors guided by structure-based drug design, imidazolones were found to successfully serve as amide bioisosteres. This novel imidazolone isosteric strategy alleviated torsional strain of the amide bond on binding to B3GNT2 and improved potency, isoform selectivity, as well as certain physicochemical and pharmacokinetic properties. Herein, we present the synthesis, SAR, X-ray cocrystal structures, and in vivo PK properties of imidazol-4-ones in the context of B3GNT2 inhibition.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要